Skip to content

RAinfo.org

Regulatory Affairs Information

  • Home
  • About RAinfo
  • Regulatory Affairs Learning
  • Regulatory Authorities
  • Regulatory Journals
  • Regulatory News RSS Feeds
  • Regulatory Newsletters
  • Regulatory Posts
  • Regulatory Tools

Draft Guidance Covers Using URRAs in Combo Product Applications​Regulatory Affairs

Written by

 A use-related risk analysis (URRA) can be used in all phases of the medical product lifecycle.

​

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook

Like this:

Like Loading...

Related

July 10, 2024 ·

Post navigation

« Secretary-General of ASEAN meets with Chairman and President of Hong Kong Green Finance Association​ASEAN Main Portal
RWS to be Applicable in GBA: New Regulation on Devices Urgent Use Policy Reveals​China Med Device »
Powered by WordPress.com. Theme: Edda by Mel Choyce
Translate »

Discover more from RAinfo.org

Subscribe now to keep reading and get access to the full archive.

Continue reading

%d